India Guidance Makes Sponsors Responsible for Trial Deaths

Clinical Trials Advisor
A A
Sponsors of clinical trials in India must begin reporting all deaths that occur “in clinical trials,” under final guidance issued March 3 by the Central Drugs Standard Control Organization.

To View This Article:

Login

Subscribe To Clinical Trials Advisor